MedPath

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting

Not Applicable
Completed
Conditions
Human Immunodeficiency Virus (HIV)
Interventions
Behavioral: PrEP Information (Active Control)
Behavioral: Sexual Health Counseling
Behavioral: Enhanced Adherence Intervention
Behavioral: Standard of Care Adherence Support (Active Control)
Registration Number
NCT02037594
Lead Sponsor
Hunter College of City University of New York
Brief Summary

This study identifies social and behavioral factors likely to influence PrEP acceptability and adherence among men who have sex with men (MSM), and collaborates with a community health center to evaluate a two-stage intervention to improve PrEP decision-making, as well as persistence and adherence for those who chose to take PrEP.

Detailed Description

Pre-exposure prophylaxis (PrEP) refers to daily or intermittent oral administration of antiretroviral drugs designed to protect high-risk HIV-negative individuals from infection. In order for PrEP to become an effective prevention tool, three critical factors must be addressed: a) acceptability, i.e., individuals who would benefit from PrEP must know about it and be willing to take it; b) adherence, i.e., individuals who choose to PrEP as a prevention strategy must take the pills as prescribed; and c) implementation, i.e., processes and protocols must be developed to allow for the integration of PrEP delivery and programs into real world settings in a way that is feasible, scalable, and realistic. This project has three specific aims: 1) Identifying social and behavioral factors that are likely to influence PrEP implementation, acceptance, and use/adherence by men who have sex with men (MSM) in NYC, including factors at individual-, community-, and organizational-levels; 2) Examining social and behavioral factors associated with disparities in access to prevention and care services among MSM in NYC that might directly impact PrEP implementation programs and policies; and 3) Evaluating an intervention in which PrEP is introduced, provided, and supported as part of a prevention package delivered in an community health center. The project has the potential to exert a sustained and powerful influence not only on the effectiveness of PrEP interventions for MSM, but also on dissemination and scalability of a targeted intervention within community-based settings and in a manner that reduces disparities in access and maximizes cultural competence and acceptability.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
438
Inclusion Criteria
  • Registered patient receiving medical or health services at Callen-Lorde Community Health Center
  • Male sex (at birth) and reported sex with men or transwomen
  • At least 18 years of age
  • HIV-negative
  • At risk for HIV acquisition
Exclusion Criteria
  • Past history of PrEP use or currently taking PrEP

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Counseling + Enhanced AdherenceEnhanced Adherence InterventionSexual Health Counseling followed by Enhanced Adherence Intervention
Information + SOC AdherencePrEP Information (Active Control)PrEP Information followed by Standard of Care Adherence Support
Counseling + SOC AdherenceSexual Health CounselingSexual Health Counseling followed by Standard of Care Adherence Support
Counseling + Enhanced AdherenceSexual Health CounselingSexual Health Counseling followed by Enhanced Adherence Intervention
Information + Enhanced AdherencePrEP Information (Active Control)PrEP Information followed by Enhanced Adherence Intervention
Counseling + SOC AdherenceStandard of Care Adherence Support (Active Control)Sexual Health Counseling followed by Standard of Care Adherence Support
Information + SOC AdherenceStandard of Care Adherence Support (Active Control)PrEP Information followed by Standard of Care Adherence Support
Information + Enhanced AdherenceEnhanced Adherence InterventionPrEP Information followed by Enhanced Adherence Intervention
Primary Outcome Measures
NameTimeMethod
PrEP PersistenceBL through 12-months

Whether or not patients who decide to take PrEP persist with the medication for the duration of the study.

PrEP UptakeBL through 3-months

Whether or not the patient decides to take PrEP

Sexual Risk BehaviorBL through 12-months

Measured through STI testing and self-report.

PrEP AdherenceBL through 12 months

Biological measure of medication adherence using dried blood spots, and self-report measure of adherence using VAS.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Callen-Lorde Community Health Center

🇺🇸

New York, New York, United States

Callen-Lorde Community Health Center
🇺🇸New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath